SH2 domain-containing inositol-5=-phosphatase-1 (SHIP1) inhibits inflammation by hydrolyzing phosphoinositide-3=-kinase generated membrane phosphatidylinositol-3,4,5-trisphosphate (PIP 3 ). Bioinformatic analysis of SHIP1 from multiple species revealed a pleckstrin homololgy-related (PH-R) domain, which we hypothesize mediates SHIP1's association with the membrane, a requirement for its biological function. Recombinant murine SHIP1 PH-R domain was subjected to biophysical and biochemical analysis. Residues K370 and K397 were found to be important for PH-R domain association with membrane PIP 3 . Wildtype PH-R domain bound PIP 3 with 1.9 ؎ 0.2 nM affinity, while the affinity of a K370A/K397A substituted mutant was too low to measure. Wild-type (but not the K370A/K397A substituted) full-length SHIP1 protein, reconstitutes normal inhibition of Fc␥ receptor-mediated phagocytosis when introduced into SHIP1 ؊/؊ murine macrophages, reducing the number of phagocytic events by 2-fold as compared to SHIP1 ؊/؊ cells. In fact, the PH-R-mediated membrane interaction appears to be a major mechanism by which SHIP1 is recruited to the membrane, since the K370A/ K397A substitution reduced the recruitment of both full-length SHIP1 and the PH-R domain by >2-fold. We have previously shown that SHIP1 enzyme activity can be targeted for therapeutic purposes. The current studies suggest that molecules targeting the PH-R domain can also modulate SHIP1 function. Src homology 2 (Sh2) domain-containing inositol-5=-phosphatase-1 (SHIP1), a 145-kDa enzyme expressed predominantly in hemopoietic cells, plays an important role in inhibiting inflammatory and immune cell function (1). Dysregulated SHIP1 function or expression is associated with inflammatory disease in both mouse models (2-4) and human populations (5). In response to ligand activation of cell surface receptors, SHIP1 is classically thought to be recruited from the cytoplasm to the cell membrane via either its SH2 domain (to receptor phosphotyrosines) or via its SH3 binding motifs (to receptor-associated SH3 domain-containing proteins). At the membrane, SHIP1 hydrolyzes phosphoinositide-3= kinase (PI3K)-generated phosphatidylinositol-3,4,5-P 3 (PIP 3 ) and thereby attenuates PIP 3 -dependent signaling events.
Src homology 2 (Sh2) domain-containing inositol-5=-phosphatase-1 (SHIP1), a 145-kDa enzyme expressed predominantly in hemopoietic cells, plays an important role in inhibiting inflammatory and immune cell function (1) . Dysregulated SHIP1 function or expression is associated with inflammatory disease in both mouse models (2-4) and human populations (5) . In response to ligand activation of cell surface receptors, SHIP1 is classically thought to be recruited from the cytoplasm to the cell membrane via either its SH2 domain (to receptor phosphotyrosines) or via its SH3 binding motifs (to receptor-associated SH3 domain-containing proteins). At the membrane, SHIP1 hydrolyzes phosphoinositide-3= kinase (PI3K)-generated phosphatidylinositol-3,4,5-P 3 (PIP 3 ) and thereby attenuates PIP 3 -dependent signaling events.
SHIP1 is an attractive target for the treatment of hemopoietic disorders, since small-molecule activators and inhibitors of SHIP1 phosphatase activity both show potential benefits in different disease contexts (6 -8) .
We have described small-molecule activators of SHIP1, which inhibit immune cell activation and hemopoietic tumor growth (8, 9) . In studying the mechanism of action of these SHIP1 agonists, we found that they bind to a previously undescribed C2 domain, which regulates SHIP1's phosphatase activity in an allosteric manner (8) . Thus, SHIP1 must both translocate to the cell membrane and interact with its physiological allos-teric activator, phosphotidylinositol-3,4-bisphosphate (PI-3,4-P 2 ), to become fully functional. During the course of those studies, we identified another domain N-terminal to the phosphatase domain. This domain does not appear to contribute to the allosteric activation but does appear to be needed for SHIP1's membrane translocation. This is especially evident during Fc␥ receptor (Fc␥R)-mediated phagocytosis in macrophages.
The intracellular uptake of particles via phagocytosis is essential to both the host's innate immune system defense against pathogens, as well as to processing of antigens to present to cells of the acquired immune system. Phagoctyosis is a dynamic process involving the coordinated recruitment and activity of signaling proteins, lipid-modifying enzymes, and components of the cytoskeletal machinery. In Fc␥R-induced phagocytosis, immunoglobulin (Ig)-opsonized particles bind to Fc␥Rs on the surface of phagocytic cells. Clustering of ligand-bound Fc␥Rs triggers the activation of tyrosine kinases (10) and subsequently PI3Ks (11, 12) . PI3K generation of PIP 3 is essential for phagosome formation and engulfment of particles greater than 2 M in size (11, 12) . Synthesis and hydrolysis of PIP 3 follows an ordered sequence on particle ligation. Beginning at the base of the phagocytic cup, where phosphatidylinositol-4,5-bisphosphate (PI-4,5-P 2 ) is converted to PIP 3 , the wave of PIP 3 generation proceeds up the lateral edges of membrane surrounding the particle, and finally disappears immediately on phagosome sealing (13) (14) (15) (16) . Cellular levels of PIP 3 are tightly regulated by both control of PI3K activation and the presence of SHIP1 and SHIP2, which hydrolyze PIP 3 to phosphatidylinositol-3,4-bisphosphate (PI-3,4-P 2 ), and phosphatase and tensin homolog (PTEN), which generates PI-4,5-P 2 (17, 18) . Of the three phosphatases, only SHIP1 and SHIP2 are reported to localize to the phagocytic cup and participate in the observed hydrolysis of PIP 3 to PI-3,4-P 2 (19, 20) .
Macrophages overexpressing wild-type (WT) SHIP1 have attenuated phagocytosis (20) , while SHIP1 Ϫ/Ϫ cells have enhanced particle uptake (19, 20) . These observations suggest that SHIP1 is a negative regulator of phagocytosis. SHIP1 has been described to be recruited to the phagocytic cup via interactions between its SH2 domain and phosphotyrosines within immunoreceptor tyrosine activating motifs (ITAMs) on Fc␥RI and Fc␥RIIa receptors (21, 22) . Imaging of inositol lipids during phagosome formation has shown that membrane recruitment of SHIP1 to the leading edge correlates with a decreasing gradient of PIP 3 and a corresponding increase of the SHIP1 product PI-3,4-P 2 along the developing phagosome (15, 16, 23) . In addition, SHIP1 can be recruited to the phagocytic cup via the inhibitory Fc␥RIIb receptor through interactions between its SH2 domain and phosphotyrosines within immunoreceptor tyrosine inhibitory motifs (ITIMs) on Fc␥RIIb (24) .
We now describe an additional, previously unrecognized domain in SHIP1. Using nuclear magnetic resonance (NMR) spectroscopy, we demonstrate that this segment of SHIP1 adopts an independently folded structure predicted to have pleckstrin homology (PH) domain-like topology. This PH-related (PH-R) domain binds PIP 3 and is required for localization of SHIP1 to the phagocytic cup and SHIP1 inhibition of Fc␥R-mediated phagocytosis. Site-directed mutagenesis of candidate amino acid residues reveals two critical lysine residues involved in the binding. Replacement of these lysines with alanines abrogates the ability of recombinant PH-R domain to interact with PIP 3 in in vitro lipid binding assays, as well as the ability of SHIP1 protein to translocate to the phagocytic cup in macrophages to negatively regulate particle uptake. These studies provide further insight into mechanisms regulating SHIP1 function in cells and suggest that small molecules which alter PH-R domain interactions with PIP 3 may be another means of modifying SHIP1 activity for therapeutic purposes.
MATERIALS AND METHODS

SHIP1 sequence domain identification
Secondary structure and order/disorder prediction algorithms were used to identify a potentially folded region in SHIP1 adjacent to the phosphatase domain. Alignments performed using ClustalW (25) confirmed that this region is conserved among all deposited SHIP1 sequences of the various species represented in the National Center for Biotechnology Information database. To define the boundaries of the structured region more precisely, truncation and extension constructs were expressed and tested for their lipid binding ability as described below.
Expression and purification of SHIP1 PH-R domain and K397A/K370A (KAKA) mutant domain
A cDNA-encoding residue 292-401 of SHIP1 (mouse) was generated by PCR and cloned into pET28c (Novagen, Madison, WI, USA). The cDNA was inserted such that a 21-aa segment containing a 6ϫHis epitope tag was fused to the N terminus of the 111-residue protein. Constructs were transformed into Escherichia coli BL21 (DE3)-competent cells (Promega, Madison, WI, USA). Protein was expressed and purified using a method as described previously (8) . Standard site-directed mutagenesis methodologies were used to generate mutant PH-R constructs in which candidate PIP binding residues were replaced with alanines. Recombinant protein from these constructs, including the KAKA variant with K370A/K397A, were expressed and purified as described above.
The sequence of 6ϫHis affinity-tagged SHIP1 PH-R domain is MGSSHHHHHHSSGLVPRGSHMSTNRRSLIPPVTFEVKS-ESLGIPQKMHLKVDVESGKLIVKKSKDGSEDKFYSHKKILQ-LIKSQKFLNKLVILVETEKEKILRKEYVFADSKKREGFCQL-LQQMKNKHSEQ. The 6ϫHis epitope tag is underscored.
Expression and purification of the isotopically labeled PH-R domain
Uniformly labeled domains were expressed in E. coli Rosetta (DE3) cells (Novagen, Madison, WI, USA) in M9 minimal medium supplemented with 15 NH 4 Cl and 13 C 6 -D-glucose (Cambridge Isotope Laboratories, Andover, MA, USA) and vitamins according to Neidhardt et al. (26) . The protocol used was modified from Marley et al. (27, 28) to reduce consumption of isotopically labeled ingredients.
NMR sample preparation
Samples were prepared by dissolving lyophilized proteins at pH 5.8 in 20 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer with 200 mM Gdn-HCl, and 5 mM tris(2-carboxyethyl)phosphine (TCEP).
NMR spectral assignments
Spectra of the 131-residue 13 C/ 15 N-labeled His 6 -tagged PH-R domain were recorded at 25°C on a 600-MHz Varian INOVA spectrometer (Varian, Inc., Palo Alto, CA, USA)equipped with a cryogenic triple-resonance probe head, using standard sensitivity-enhanced gradient Varian BioPack pulse sequences (29 -33) , including 1 H-15 N heteronuclear single-quantum correlation (HSQC), HNCACB (30) , CBCA(CO)NH (31), HNCO (32) , and HN(CA)CO (33) . Spectra were processed with NMRPipe (34) and subsequently exported to Sparky for analysis (35) . 1 H chemical shifts were referenced to external 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) at 25°C (36) . 15 N and 13 C were referenced using recommended magnetogyric ratios (37) .
NMR-monitored titrations
The interaction of PIP 3 diC8 (Echelon Biosciences, Salt Lake City, UT, USA) with the PH-R domain was monitored by 1 Ϫ/Ϫ ) cell lines were generated by infecting bone marrow-derived macrophages (BMMs) from C57BL6 SHIP1 ϩ/ϩ and SHIP1 Ϫ/Ϫ mice, respectively, with the J2 virus (38) and maintained in Iscove's modified Dulbecco's medium (Thermo Scientific), supplemented with 10% FBS, 10 M ␤-mercaptoethanol, 150 M monothioglycolate, and 1 mM L-glutamine. J17 cells were transduced with lentiviruses harboring expression constructs for WT SHIP1 or SHIP1 with residues K370 and K397 mutated to alanines (KAKA) under the control of a tetracycline-responsive promoter. Transduced cells were separated from nontransduced cells by fluorescence-activated cell sorting based on the coexpression of mCherry on the lentiviral transfer plasmid. Transduced cells were treated with 2 g/ml of doxycycline (Sigma) for 48 h to induce WT or KAKA SHIP1 expression prior to use. Expression of WT and KAKA SHIP1 was confirmed by resolving cell lysates by SDS-PAGE and immunoblotting using anti-SHIP1 (P1C1) antibody (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Intensities of bands were quantified using the Bio-Rad Quantity One software (Bio-Rad, Hercules, CA, USA).
Green fluorescent protein (GFP)-tagged SHIP PH-R domains
eGFP fusion constructs were generated by inserting PCRgenerated cDNA fragments corresponding to SHIP1 residues 292-401 and AKT1 residues 1-165 into the pEGFP-C1 vector (Clontech, Mountain View, CA, USA) using EcoRI and BamHI restriction cut sites. Plasmid constructs were then transiently transfected into RAW264.7 cells using FuGene HD (Roche, Laval, QC, Canada) as per the manufacturer's protocol.
Scintillation proximity assays (SPAs)
Copper chelate YSi SPA Scintillation Beads (GE Healthcare, Piscataway, NJ, USA) were diluted in 0.25% BSA in Trisbuffered saline to 1.5 mg/ml. Each His 6 -tagged SHIP1 C2 domain or PH-R domain (10 nM) was allowed to bind to the beads by incubating at 23°C for 1 h. Aliquots (250 g) of domain-coated beads were added to each well of a 96-well plate. [ 3 H]-AQX-MN100 (0.185 MBq; 5 Ci)was then added to each well and incubated for 30 min with gentle agitation. The amount of bead-associated radioactivity was quantified by counting in a Wallac Betaplate scintillation counter (PerkinElmer, Waltham, MA, USA).
Phagocytosis assays
Bead preparation
Latex beads (3 m; Polysciences, Warrington, PA, USA) were opsonized with 100 g/ml human IgG (Sigma) or human IgG labeled with a DyLight 488 conjugating kit (Thermo Scientific) overnight at 37°C with gentle agitation. Beads were washed with PBS and resuspended in cold DMEM supplemented with 9% FBS.
Cell preparation
, and J17 SHIP Ϫ/Ϫ cells reconstituted with SHIP WT (SHIP1 Ϫ/Ϫ : WT) or J17 SHIP Ϫ/Ϫ cells reconstituted with SHIP KAKA (SHIP1 Ϫ/Ϫ : KAKA) were plated onto poly-l-lysine-treated glass coverslips and allowed to adhere overnight at 37°C, 5% CO 2 .
Bead stimulation
Overnight supernatants were removed and replaced with opsonized beads at a 10 beads:1 cell ratio. Plates were centrifuged at 4°C to allow beads to settle onto the coverslips; then plates were immediately placed in a 37°C, 5% CO 2 incubator for phagocytosis to proceed.
Slide preparation
Stimulated cells were washed with cold PBS, fixed in 2% paraformaldehyde (10 min at room temperature), permeabilized with 0.1% Triton X-100 in PBS, blocked with 3% BSA in PBS, stained with Alexa Fluor 647 Phalloidin to detect polymerized, filamentous actin (F-actin; Invitrogen), then mounted onto glass slides using Prolong Gold antifade reagent (Invitrogen). Images were acquired using a Zeiss LSM780 confocal microscope with a ϫ63 oil-immersion lens (Carl Zeiss, Oberkochen, Germany). For immunocytochemistry experiments, cells were additionally stained with primary mouse anti-SHIP1 (P1C1) antibody (Santa Cruz Biotechnologies), followed by FITC-conjugated goat anti-mouse secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA, USA).
Quantification of fluorescence of cells fixed on coverslips
As described by Botelho et al. (39) , Zeiss Zen 2009 software was used to mark 3.5-m length line scans (indicated by a blue line in the merged confocal images) traversing the phagocytic cup on a path tangential to the latex bead being ingested. The fluorescence intensities for GFP fusion domain, FITC-stained SHIP1, or Alexa Fluor 647 were summed at every 0.4-m interval along the line scan and expressed either F-actin fluorescence alone, or as a ratio of green (GFP fusion domain or FITC-stained SHIP1) to red (F-actin) fluorescence.
Flow cytometric phagocytosis assay
As described by Lehmann et al. (40) , cells stimulated with Dylight 488-human IgG-opsonized beads were washed 3 times with ice-cold PBS, then fixed in 2% paraformaldehyde (10 min at room termperature). Cells were resuspended in 3% FCS/PBS, incubated with anti-CD16/32 antibody (Fc Block; BD Biosciences, Mississauga, ON, Canada) for 30 min at 4°C, incubated for an additional 30 min with allophycocyanin (APC) anti-human Ig (BD Biosciences), washed 3 times with 3% FCS/PBS, then analyzed on a BD FACS CantoII flow cytometer. 10,000 APC-negative events (to exclude cells with partially phagocytosed beads) were collected and analyzed with FlowJo 8.7 software (TreeStar Inc., Ashland, OR, USA).
Production of recombinant SHIP1 WT and SHIP1 KAKA
To produce large quantities of full-length N-terminal His 6 -tagged WT or KAKA SHIP1 necessary for PLO assays, recombinant enzymes were produced in Sf9 cells using a baculovirus expression system (Invitrogen). For in vitro phosphatase assays, full-length WT or KAKA SHIP1 enzyme was produced by polyethyleneimine transient transfection of HEK 293T cells. For both expression methods, cells were pelleted and lysed, and recombinant enzyme was purified from lysates using TALON cobalt affinity chromatography resin (Clontech) and determined to be more than 95% pure as described above.
In vitro phosphatase assays
SHIP1 enzyme assays were performed as described previously (8) .
RESULTS
Identification of a PH-related (PH-R) domain in SHIP1
Because our study of the enzymatic properties of SHIP1 revealed that it is allosterically activated by its product PI-3,4-P 2, we searched for potential PI-3,4-P 2 binding domains within SHIP1 (8) . Alignment of amino acid sequences of SHIP1 and SHIP2 from multiple species, and secondary structure predictions, led to the identification of a C2 domain that bound PI-3,4-P 2 and was necessary for the allosteric regulation of SHIP1's phosphatase activity (8) . Amino acid alignments ( Fig. 1) and secondary structure predictions also revealed a second 110-aa region N-terminal to the phosphatase domain that had features of a PH domain (Fig. 2) .
To characterize this newly recognized region of SHIP1, residues 290 -410 were cloned and expressed for NMR spectroscopic analysis. As shown in Fig. 3A , the resulting protein fragment yielded a well-dispersed 1 H-15 N HSQC spectrum, confirming that this segment of SHIP1 indeed adopts an independently folded structure. After assigning the signals from the mainchain 1 H, 13 C, and 15 N nuclei of this species (Fig. 3B ), the chemical shift-based SSP algorithm (41) was used to identify its secondary structural elements (Fig. 3C) . Consistent with the sequence-based secondary structure predictions (Fig. 2B-D) , the SHIP1 domain contains several ␤-strands, as well as a clear C-terminal helix.
Unfortunately, although having an assignable 1 H-15 N HSQC spectrum, residues 290 -410 of SHIP1 also exhibited unfavorable dynamic properties leading to extensive conformational exchange broadening of the NMR signals from side-chain nuclei. This prevented us from determining its tertiary structure using NMRmeasured restraints. Therefore, we used the THRIFTY webserver (42) to predict the fold of the SHIP1 domain based on chemical shift-guided homology threading. This program essentially finds residues in the database of NMR derived structures that have similar chemical shifts to a query protein. With two perpendicular ␤-sheets followed by a C-terminal ␣-helix, the resulting model has the overall fold characteristic of a PH domain (Fig. 3D) . However, it is important to note that PH domains show significant variation in sequence, structure, and function, reviewed by Lemmon (43, 44) . Accordingly, in the absence of a more detailed structural analysis, we conservatively denote this region of SHIP1 as a PH-R domain.
Functional characterization of the PH-R domain
To test the ability of this PH-R domain within SHIP1 to bind PIPs in vitro, we expressed N-terminal His 6 -tagged PH-R protein in E. coli and purified it for in vitro studies. Much of the PH-R protein was found as insoluble inclusion bodies but ϳ10% existed in a soluble form that we purified by Cobalt-chelating affinity chromatography from Nonidet P-40 lysates. We tested the ability of the PH-R domain to bind PIPs in a PLO assay (8) . PVDF membranes were spotted with 0 to 50 pmol of PI-4,5-P 2 , PIP 3 , or PI-3,4-P 2 and incubated with 0 to 625 nM of His 6 -PH-R protein. Figure 4A shows a representative PLO blot, and the quantification is summarized in Fig.  4B . The SHIP1 PH-R domain bound to PIP 3 more strongly than either PI-4,5-P 2 or PI-3,4-P 2 . To calculate the binding affinities of the PH-R domain to each of the phosphatidyl inositol lipids, we plotted double-reciprocal graphs (45) of the data shown in Fig. 4B (Supplemental Fig. S1A ). On the basis of this analysis, the equilibrium dissociation constant, K D , of the PH-R domain/PIP 3 complex was found to be 1.9 Ϯ 0.2 nM. The K D values for the PI-4,5-P 2 and PI-3,4-P 2 could not be determined with precision by this approach, giving estimates of ϳ10 nM for both lipids. In parallel, we also used NMR spectroscopy to confirm that the isolated PH-R domain binds PIP 3 (Fig. 3A, blue) .
In previous studies, we described the allosteric activation of SHIP1 phosphatase activity by its product, PI-3,4-P 2 , and by a small-molecule agonist, AQX-MN100 (8) . We found that a region in SHIP1 designated as the C2 domain was responsible for binding and mediating this allosteric activation. Because of the observed PI-3,4-P 2 binding of the PH-R domain, we tested whether it might also bind AQX-MN100. We compared the ability of the PH-R and C2 domains to bind [ 3 H]-AQX-MN100 using SPA beads coated with recombinant PH-R or C2 protein. Figure 4C shows that the C2 domain binds AQX-MN100, as described previously (8) . In contrast, the PH-R domain and the BSA negativecontrol protein exhibit similar levels of [ 3 H]-AQX-MN100 binding. Thus, the PH-R domain does not measurably bind this compound.
We next determined whether the PH-R domain behaved like other PIP 3 -binding PH domains in cell-based assays. Fc␥R-mediated phagocytosis is associated with activation of PI3K, which causes a rapid and transient accumulation of PIP 3 at the phagocytic cup (11, 12) . The Akt-PH domain preferentially interacts with 3=-phosphoinositides and binding of PIP 3 and PI-3,4-P 2 by an N-terminal GFP fusion of this domain has been well characterized in cells (15, 46) . We constructed a similar N-terminal fusion protein of the SHIP1 PH-R domain and transiently expressed either the Akt-PH domain GFP Fusion, SHIP1 PH-R domain GFP fusion, or GFP alone in RAW264.7 macrophage cells. Transfected cells were plated onto coverslips, exposed to Ig-coated 3-m latex beads (Igopsonized beads) for the indicated length of time (Fig. 5B) , fixed, and stained with Alexa Fluor 647-phalloidin to detect polymerized F-actin. As shown in Fig. 5A , in the plane in which the confocal images are acquired, cells are circumscribed by a ring of F-actin associated with adherence to the coverslip. The addition of opsonized beads (indicated by arrowheads) induces formation of a phagocytic cup around which more F-actin accumulates (Fig. 5A, B, left panel) . We quantified fusion domain recruitment from the cytoplasm to the phagocytic cup by using Zeiss Zen 2009 software to determine the ratio of green (GFP fusion domain or GFP alone) to red (F-actin) fluorescence associated with the phagocytic cup (Fig. 5B,  right panel) . As shown in Fig. 5B , the SHIP1 PH-R domain translocated to the forming phagocytic cup with similar kinetics to the Akt-PH domain peaking at ϳ5 min poststimulation, whereas GFP alone did not exhibit any defined localization.
Identification of amino acid residues involved in PIP 3 binding
To identify the specific amino acid residues involved in PIP 3 binding, we expressed PH-R mutant proteins in which alanines were substituted for candidate residues (Supplemental Fig. S2 ). These residues were chosen on the basis of their conservation among the 14 SHIP1 orthologs (Fig. 1) and their charge and/or sequence proximity to positively charged residues, which could potentially mediate an interaction with the negatively charged PIP 3 inositol headgroup. Unfortunately, few clues were provided from the NMR-monitored titrations shown in Fig. 3A , as residues showing chemical shift perturbations on PIP 3 binding were distributed broadly over the model of the PH-R domain. The lack of a clearly defined binding site could reflect indirect conformational changes of the rather dynamic protein domain (Fig. 3B) , as well as the possibility of multiple binding interfaces.
As before, His 6 -tagged proteins were expressed in E. coli, purified, and tested for their ability to bind PIPs in a PLO assay (Supplemental Fig. S2 ). Of the 10 mutant domains analyzed, 2 lysine to alanine mutants, K370A and K397A, consistently exhibited impaired abilities to bind PIP 3 and PI-3,4-P 2 (Fig. 6) . The K D values for the mutant domains could not be determined, as these proteins bound PIP 3 and PI-3,4-P 2 with such low affinity that we were not able to saturate binding (Supplemental Fig. S1B ). We then constructed a double-mutant domain where both K370 and K397 residues were substituted with alanines (KAKA). The resulting KAKA PH-R mutant exhibited a further reduction in PIP 3 and PI-3,4-P 2 binding, as compared to either of the individual point mutation domains (Fig. 7A) . Interestingly, the WT and KAKA mutant proteins bound PI-4,5-P 2 equally well. The 1 H- 15 N-HSQC spectrum of the KAKA PH-R domain was also well dispersed, indicating that the loss of PIP 3 and PI-3,4-P 2 binding ability is not due to a disruption of global protein structure (Fig. 7B) .
Dowler et al. (47) suggest a PIP binding motif for PH domains of the form K-X-small-X(6-11)-R/K-X-R-hydrophobic-hydrophobic. The SHIP1 PH-R domain has a region, including one of the critical lysines (K370) and spanning residues 334 -372 that has a similar form of KDG-X(31)-JEKIL (Fig. 3D) . The second critical lysine residue, K397 is not involved in respectively. The high degree of signal intensity variation is attributed to a range of conformational dynamic exchange exhibited in the isolated PH-R domain. C) SSP scores determined from 13 C␣ and 13 C␤ chemical shifts experimentally identify the helical (ϩ1) and strand (Ϫ1) regions in the PH-R domain (39) . D) Model generated with THRIFTY (40) using chemical shift information to guide molecular homology threading demonstrates that residues 292-401 of SHIP1 adopt a PH domain-like fold. Highlighted in yellow is a possible PIP binding motif similar to that proposed by Gupta et al. (57) . Also shown in magenta are the side chains of K370 and K397. this motif, but rather is in the C-terminal helix (47) . It is possible that K397 is part of a second binding interaction that binds PIP 3 via basic residues between the C-terminal helix and the adjacent ␤-strand in a manner similar to phox homology (PX) domain binding (48) .
KAKA PH-R protein has impaired localization to the phagocytic cup
We then examined the ability of the KAKA PH-R domain to be recruited to the phagocytic cup in RAW264.7 macrophages stimulated with Ig-opsonized beads. RAW264.7 cells were transfected as above with WT PH-R-GFP, KAKA PH-R-GFP, or GFP, exposed to Ig-opsonized beads and stained with Alexa Fluor 647-phalloidin to detect polymerized F-actin. The amount of GFP fluorescence and F-actin associated with the phagocytic cup was quantified as in Fig. 5 . Figure 7D shows the amount of F-actin (left panel) and the amount of GFP expressed as a ratio of GFP fluorescence/F-actin fluorescence (right panel) associated with the phagocytic cup. The amount of WT PH-R domain recruited to the phagocytice cup was Ն2ϫ more than the KAKA PH-R domain (Fig.  7D, right panel) . These results implicate residues 
SHIP1 with the KAKA substitution is still subject to allosteric regulation
To further define the consequence of K370/K397 mutations on SHIP1 function, we expressed full-length WT SHIP1 and SHIP1 containing the KAKA mutations and compared their ability to bind PIP 3 in vitro. His 6 -tagged proteins were expressed and purified from Sf9 cells and their PIP 3 binding ability assessed by PLO, as described previously. As seen in Fig. 8A , KAKA SHIP1 had significantly lower PIP 3 binding than WT SHIP1. This confirms that the PH-R domain and the K370/ K397 residues, in particular, contribute to SHIP1's interaction with PIP 3 .
We then compared the enzymatic properties of WT and KAKA SHIP1 and found their catalytic rates and specific activities indistinguishable (Fig. 8B) . We also examined the ability of the KAKA SHIP1 enzyme to be stimulated by SHIP1's allosteric activators, PI-3,4-P 2 and AQX-MN100. The addition of either PI-3,4-P 2 or AQX-MN100 enhanced the phosphatase activity of both WT and KAKA SHIP1 (Fig. 8C) . Altogether, while K370A/ K397A mutations interfere with SHIP1's ability to interact with PIP 3 , its catalytic activity and allosteric activation remain unaltered, suggesting that these two residues only facilitate SHIP1's localization to PIP 3 and that this process is independent of SHIP1's catalytic domain.
SHIP1 with the KAKA substitution is not able to inhibit Fc␥-R mediated phagocytosis
We next investigated the impact of the KAKA substitutions on the function of SHIP1 protein in Fc␥R-mediated phagocytosis. BMM cell lines were established from SHIP1 ϩ/ϩ and SHIP1 Ϫ/Ϫ mice (see Materials and Methods). Using lentivirus-mediated gene transfer, we reconstituted the SHIP1 Ϫ/Ϫ macrophage cell line with either full-length WT or KAKA SHIP1 protein. SHIP1 expression in the SHIP1 ϩ/ϩ , SHIP1 Ϫ/Ϫ , and SHIP1
Ϫ/Ϫ cells reconstituted with WT and KAKA SHIP1 is shown in Fig. 9A . Note that the expression levels of WT and KAKA SHIP1 are similar, but both are ϳ70% less than that of endogenous SHIP1 in the SHIP1 ϩ/ϩ cell line. Difficulty in obtaining high-level expression of SHIP1 has been reported previously (49) and is attributed to the fact that ectopic/overexpression of SHIP1 inhibits growth and survival.
Using immunoflourescence confocal microscopy, we tested the ability of full-length WT and KAKA SHIP1 to be recruited to the phagocytic cup in the reconstituted cell lines. Cells were incubated with latex beads opsonized with human IgG for the times indicated, fixed, permeabilized, and stained with anti-SHIP1 antibody, followed by a fluorescently labeled secondary detection antibody (green); cells were also stained with Alexa Fluor 647-phalloidin to detect polymerized F-actin (Fig.  9B) . The kinetics of F-actin (Fig. 9C, left panel) and WT SHIP1 (Fig. 9C, right panel) recruitment to the phagocytic cup peaks later than in the experiments shown in Figs. 5 and 7, likely because RAW264.7 cells were used in those experiments. As shown in Fig. 9C (right panel) , Figure 6 . Mutation of SHIP1 PH-R domain residues K370 and K397 to alanines impairs its ability to interact with PIP 3 . PLO assays were performed and quantified as previously described for each of PI-4,5-P 2 , PIP 3 , and PI-3,4-P 2 (spotted at the amounts indicated) with 625 nM of recombinant WT SHIP1 PH-R domain and K370A (A), or K397A (B) mutant PH-R domains. Data are expressed as mean Ϯ sd intensities and are representative of 3 independent experiments. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001; 2-way ANOVA. at 15 min there was 2.5ϫ more WT SHIP1 protein at the phagocytic cup than KAKA SHIP1, indicating that K370A and K397A mutations impair SHIP1's localization to PIP 3 being produced at the phagocytic cup.
As described by others, SHIP1 Ϫ/Ϫ cells phagocytose more rapidly and ingest more latex beads per cell than SHIP1 ϩ/ϩ cells (19, 20) . This suggests that SHIP1 has a role in the negative regulation of Fc␥R-mediated phagocytosis. To correlate our observations of impaired SHIP1 recruitment in KAKA SHIP1 reconstituted cells with phagocytic function, we measured the ability of our SHIP1 ϩ/ϩ , SHIP1 Ϫ/Ϫ cells, and WT and KAKA SHIP1 reconstituted cells to phagocytose beads using a FACS-based phagocytosis assay (40) in conjunction with beads coated with fluorochrome (Dylight488) labeled Ig as described in Materials and Methods. Figure 10A shows the FACS profile of cells alone (left) or WT cells allowed to phagocytose the Dylight 488-Ig beads (right). The right-hand panel of Fig. 10A shows that cells that have taken up 0, 1, or Ն2 beads can be separated by their degree of Dylight 488 fluorescence. The number of cells within each region was quantified using FlowJo flow cytometry software and plotted in Fig.  10B . As reported previously (19, 20) , SHIP1
Ϫ/Ϫ phagocytosed more beads than SHIP1 ϩ/ϩ cells, with the difference being most evident when one looks at the number of cells that take up Ն2 beads (2-fold greater numbers of SHIP1 Ϫ/Ϫ as compared to SHIP1 ϩ/ϩ cells take up Ն2 beads). Reconstitution of SHIP1
Ϫ/Ϫ cells with WT SHIP1 partly restored the behavior to that observed in SHIP1
ϩ/ϩ cells. The partial nature of the restoration is likely due to the fact that reconstituted cells had overall lower expression levels of SHIP1 than SHIP1 ϩ/ϩ cells (Fig. 9A) . However, reconstitution of SHIP1 Ϫ/Ϫ with KAKA SHIP1 failed to reduce phagocytic activity at all.
DISCUSSION
Fc␥R-mediated phagocytosis is essential for removal of antibody-opsonized foreign particles. On ligation of Fc␥R on the macrophage cell membrane, ITAMs on the cytoplasmic tail of the Fc␥R become phosphorylated and provide docking sites for SH2-domain-containing signaling proteins, including Syk (50, 51) and PI3K (11, 51) . Once recruited to the membrane, these proteins initiate dynamic changes in membrane lipid composition and the actin cytoskeleton necessary for phagocytic cup formation, particle internalization, and phagosome maturation. SHIP1 has also been demonstrated to be recruited to the phagocytic cup via interaction of its SH2 domain with phosphotyrosines within ITAMs, where it negatively regulates phagocytosis, presumably by degrading PIP 3 (21, 22) . SHIP1 has additionally been shown to interact with the tyrosinephosphorylated ITIMs on the inhibitory Fc␥RIIb (24) . However, our data suggest that SHIP1 recruitment to the phagocytic cup might be mediated predominantly through lipid-protein rather than protein-protein interactions. The lipid-mediated recruitment changes our understanding of the processes regulating phagocytosis.
We describe a PH-R domain in SHIP1 that possesses structural and functional similarities with members of the PH domain family. Although PH domains have been reported to bind a variety of ligands, their interaction with phosphoinositol lipids is the best characterized (52) . As shown herein, SHIP1's PH-R domain binds to PIP 3 and also to PI-3,4-P 2 and PI-4,5-P 2 , albeit with lower affinity, and that the interaction with PIP 3 is mediated either directly or indirectly by Ն2 key lysine residues at positions 370 and 397. The 1 H-15 N-HSQC NMR spectra of WT and KAKA PH-R domains confirmed that mutation of these two lysines does not interfere with global conformation or proper folding (Fig. 7B) . However, we and Edlich et al. (53) have observed numerous spectral differences between WT and lysine residue substituted domains, which suggest that the substitutions themselves cause some conformational perturbations. Further work is under way to determine whether impaired inositol lipid binding caused by replacing K370 and K397 with alanines is due to the lack of direct interactions of these lysine residues with the inositol headgroups, or instead due to substitution-induced changes in local conformation. Interestingly, while mutation of these two residues to alanines significantly reduces the ability of the PH-R domain to interact with PIP 3 and PI-3,4-P 2 , binding to PI-4,5-P 2 remains relatively unaltered. If K370 and K397 are directly involved in lipid binding, then these positively charged lysine residues could possibly facilitate stable interaction with PIP 3 via coordination with the negatively charged phosphate at the 3= position of the inositol headgroup, whereas other residues in the PH-R domain are required for binding to PI-4,5-P 2 .
The binding of PIP 3 and PI-3,4-P 2 by the PH-R domain could serve several functions. PIP 3 is a SHIP1 substrate, so the PH-R domain might recruit PIP 3 to the enzyme and transfer it to the phosphatase domain. However, this seems unlikely, since although substituting lysine residues 370 and 397 with alanine significantly impairs the ability of the domain to bind PIP 3 , this does not alter SHIP1's basal phosphatase activity. PI-3,4-P 2 , a product of SHIP1 hydrolysis of PIP 3 , is an allosteric activator of SHIP1 phosphatase activity (8) , so the PH-R domain might be involved in PI-3,4-P 2 -mediated activation of SHIP1's enzymatic activity. However, this also seems unlikely, since although the KAKA Figure 8 . Mutation of residues K370 and K397 to alanines in full-length SHIP1 abrogates in vitro PIP 3 binding ability but does not affect its phosphatase activity. A) PLO assays were performed and quantified as previously described for PIP 3 spotted at 50 pmol with a titration of recombinant full-length WT or KAKA SHIP1 enzyme. Data are expressed as mean intensities Ϯ sd intensities (nϭ3). *P Ͻ 0.05. B) Initial rate enzyme kinetics for full-length WT or KAKA SHIP1 enzyme were determined using an in vitro phosphatase assay and increasing concentrations of inositol-1,3,4,5-tetrakisphosphate (IP4). Data are representative of 3 independent experiments. C) In vitro phosphatase assays were performed with recombinant, full-length WT or KAKA SHIP1 with 50 M IP4 substrate in the presence of increasing concentrations of the allosteric activators PI-3,4-P 2 and AQX-MN100. Data are expressed as mean Ϯ sd fold increases of enzyme activity (nϭ3). mutant is impaired in its ability to bind PI-3,4-P 2 , it retains its ability to be activated by both PI-3,4-P 2 and AQX-MN100 (Fig. 8C) .
The observation that mutations in the PH-R domain do not alter SHIP1's phosphatase activity is consistent with the literature reports on mutations, deletions, and truncations made in regions outside of the core 5=-phosphatase domain (54 -59) . In a study by Aman et al. (59) in which a series of SHIP1 truncations and deletions were expressed, they found the noncatalytic C-terminal region extending beyond amino acid residue 900 was necessary for Fc␥RIIB-mediated inhibition of calcium flux in DT40 chicken B cells. Interestingly, reconstitution of SHIP1
Ϫ/Ϫ cells with a SHIP1 C-terminal truncation at residue 900 (SHIP 1-900 ) was able to partially restore inhibition of calcium flux, whereas a construct that removed both the presently characterized PH-R domain and the C-terminal domain (SH2-18aa-401-900) was not. These results support our identification of SHIP1's PH-R domain and suggest that in addition to the noncatalytic C-terminal region, SHIP1's PH-R domain may also contribute to stabilizing the interaction between SHIP1 and Fc␥RIIB indirectly via binding to membrane PIP 3 . Our data suggest that the PH-R domain's main role is to mediate SHIP1's localization to the phagocytic cup during Fc␥R-mediated phagocytosis. SHIP1 transiently localizes to the phagocytic cup at the early stages of cup formation and is sequestered at the leading edge of the phagosome (15, 20, 60) . Our data show that despite having a functional SH2 domain capable of interacting with Fc␥R ITAM, KAKA SHIP1 has a significantly impaired ability to translocate to the cell membrane in cells stimulated with Ig-opsonized beads. These findings indicate that SHIP1's SH2 domain is insufficient to facilitate SHIP1's recruitment to the phagocytic cup. Zhang et al. (61) have recently proposed a model whereby the density of Fc␥R activation determines early-stage signals, such as the recruitment of Syk, while later stages of Fc␥R signaling, i.e., those that ultimately commit the cell to complete phagocytosis of a particle, are dependent on 3= PI levels (e.g., PIP 3 and PI-3,4-P 2 ) in unclosed phagocytic cups. It is thus possible that, similarly to Syk, relatively few molecules of SHIP1 are recruited to the Fc␥R on ligand binding via SHIP1's SH2 domain interacting with tyrosine phosphorylated ITAMs/ITIMs. While the magnitude of recruitment during these early-stage events is directly proportional to the density of IgG opsonization on the particles, only phagocytic cups having reached a threshold level of PIP 3 are able to successfully commit to the formation of a phagosome around a particle and concomitantly recruit large amounts of SHIP1 to the phagocytic cup possibly via its newly identified PH-R domain.
Our current understanding of phagocytosis has moved beyond the classical "zipper" model where engulfment occurs as receptors bind ligands sequentially along the surface of the particle being ingested. A review by Jaumouillé and Grinstein (62) eloquently described a model that considers the actin cytoskeletal contributions to the regulation of phagocytosis by partitioning or "fencing-off" regions of membrane to limit the lateral movement of Fc␥Rs. While actin polymerization is required for the initial filopodial extensions that are necessary for the identification and attachment of opsonized particles, their model suggests that underlying cortical actin barriers must be broken down in order for Fc␥R to move laterally and form the receptor clusters responsible for initiating the signaling cascade and actin remodeling that drives particle internalization. Applying this model to our own observations of the PH-R domain-dependent translocation of SHIP1 to the plasma membrane, we suggest that SHIP1 can be recruited to the membrane through both SHIP1-SH2/ Fc␥R phosphotyrosine and SHIP1-PH-R/PIP 3 interactions. However, the actin partitions that restrict lateral movement of transmembrane proteins prevent the aggregation of Fc␥R molecules and thus limit the amount of SHIP1 recruited by binding to phosphorylated Fc␥R ITAMs or ITIMS to levels too low to be detected by conventional immunofluorescence microscopy. On the other hand, PIP 3 would not be subject to the same restrictions in lateral motion and thus PIP 3 would be able to recruit high levels of SHIP1 (via its PH-R domain) that is easily visualized at the phagocytic cup.
Identification and characterization of SHIP1's PH-R domain now provide a more detailed illustration of the mechanism whereby SHIP1 translocates to the membrane on Fc␥R ligation and lends further insight into how SHIP1 contributes to modifications in membrane lipid composition and actin rearrangements that collectively promote particle engulfment. By interacting with PIP 3 being generated at the phagocytic cup, the PH-R domain facilitates SHIP1's rapid enrichment at the leading edge, where it can hydrolyze PIP 3 to PI-3,4-P 2 and thus regulate the progression of stages through phagosome maturation. The degradation of PIP 3 at the phagocytic cup may be only one of the mechanisms by which SHIP1 negatively regulates Fc␥R-mediated phagocytosis. Mehta et al. (63) recently described the association of SHIP1 with LyGD1, an inhibitor of the necessary membrane association of the small G protein Rac. The PIP 3 -mediated membrane localiza- tion of SHIP1 may not be limited solely to Fc␥R signaling, and future studies will seek to determine whether the PH-R domain also mediates SHIP1's recruitment to other cellular compartments and in response to other cell stimuli (64, 65) . It will also be interesting to find small molecules that modify PH-R domain interactions with PIP 3 , as these may have potential therapeutic applications.
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